CRSP
CRISPR Therapeutics AG
Stock
$55.43−0.01 (−0.02%)Close Oct 2, 2026
- Free cash flow, 2025
- −$346M
Free cash flow
Free cash flow by fiscal year
| Period | Free cash flow | YoY |
|---|---|---|
| 2025 | −$346M | — |
| 2024 | −$145M | — |
| 2023 | −$270M | — |
| 2022 | −$533M | — |
| 2021 | $457M | — |
| 2020 | −$257M | — |
| 2019 | $50M | — |
| 2018 | −$99M | — |
| 2017 | −$78M | — |
| 2016 | −$56M | — |
| 2015 | $58M | — |